Approval · Notice of Compliance 33917 · 2024
MEFENAMIC: Notice of Compliance 33917
Issued September 3, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33917
- Date
- September 3, 2024
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between tw o manufacturers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MEFENAMIC | 02229452 | Marketed |
Medicinal ingredients
- MEFENAMIC ACID 250 MG per CAP